Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Inogen Community
NasdaqGS:INGN Community
1
Narratives
written by author
2
Comments
on narratives written by author
4
Fair Values set
on narratives written by author
Create a narrative
Inogen
Popular
Undervalued
Overvalued
Community Investing Ideas
Inogen
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Yuwell Collaboration Will Open Chinese Respiratory Market
Key Takeaways Strategic partnerships and product innovation in China and digital health are expected to drive growth and improve earnings potential. Operational efficiencies and cost management are likely to enhance profitability and strengthen Inogen's balance sheet.
View narrative
US$10.00
FV
28.5% undervalued
intrinsic discount
5.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
INGN
INGN
Inogen
Your Fair Value
US$
Current Price
US$7.15
69.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-102m
429m
2015
2018
2021
2024
2025
2027
2030
Revenue US$428.7m
Earnings US$62.9m
Advanced
Set Fair Value